When patients develop fulminant hepatitis, their IL‐25 level increases, activating the signal pathway mediated by IL‐17 receptors A/B (IL‐17RA/RB) and Tpl2, leading to the expression of CXC motif chemokine ligands (CXCLs) 1/2. This evidence concerns the gene MAP3K8 and Fulminant hepatitis.